Axon Enterprise, Inc. (AXON) earnings
AXON earnings moved a median of +2.26% by the close. Quarterly and annual AXON reports and results, each read against the price at its own news timestamp. Back to the AXON overview →
35 measured AXON earnings events.
Where these AXON earnings landedvs 35 measured AXON earnings reactions
| Middle 50% of AXON earnings reactions | -1.28% to +5.99% |
|---|---|
| Median reaction (to close) | +2.26% |
| Measured reactions | 35 |
Point-in-time · zero look-ahead
Half of the 35 AXON earnings events with a measured close landed between -1.28% and +5.99%; 63% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q AXON ENTERPRISE, INC. For: Jun 30 | SEC filing · Form 10-Q | +0.46% | -10.89% | |
| Axon reports Q2 2026 revenue of $904 million, up 35% year over year | Press release | +0.46% | -10.89% | |
| Axon to Release Second Quarter 2026 Earnings on August 5, 2026 | Press release | -0.61% | -1.54% | |
| Form 10-Q AXON ENTERPRISE, INC. For: Mar 31 | SEC filing · Form 10-Q | -3.01% | +4.63% | |
| Axon reports Q1 2026 revenue of $807 million, up 34% year over year | Press release | -3.01% | +4.63% | |
| Axon to Release First Quarter 2026 Earnings on May 6, 2026 | Press release | -2.88% | -1.70% | |
| Form 10-K AXON ENTERPRISE, INC. For: Dec 31 | SEC filing · Form 10-K | +2.76% | +3.99% | |
| Axon reports Q4 2025 revenue of $797 million, up 39% year over year | Press release | +2.76% | +3.99% | |
| Axon to Release Fourth Quarter 2025 Earnings on February 24, 2026 | Press release | -2.78% | -4.18% | |
| Form 10-Q AXON ENTERPRISE, INC. For: Sep 30 | SEC filing · Form 10-Q | +0.75% | +12.92% | |
| Axon reports Q3 2025 revenue of $711 million, up 31% year over year | Press release | +0.75% | +12.92% | |
| Axon to Release Third Quarter 2025 Earnings on November 4, 2025 | Press release | -0.60% | -1.22% | |
| Form 10-Q AXON ENTERPRISE, INC. For: Jun 30 | SEC filing · Form 10-Q | +6.15% | +6.00% | |
| Axon reports Q2 2025 revenue of $669 million, up 33% year over year | Press release | +6.15% | +6.00% | |
| Axon to Release Second Quarter 2025 Earnings on August 4, 2025 | Press release | -0.75% | -3.77% | |
| Axon reports Q1 2025 revenue of $604 million, up 31% year over year | Press release | +2.93% | +5.99% | |
| Form 10-K/A AXON ENTERPRISE, INC. For: Dec 31 | SEC filing · Form 10-K | +2.93% | +5.99% | |
| Form 10-Q AXON ENTERPRISE, INC. For: Mar 31 | SEC filing · Form 10-Q | +2.93% | +5.99% | |
| Axon to Release First Quarter 2025 Earnings on May 7, 2025 | Press release | +0.89% | +2.21% | |
| Form 10-K AXON ENTERPRISE, INC. For: Dec 31 | SEC filing · Form 10-K | +0.69% | -1.33% | |
| Axon to Release Fourth Quarter 2024 Earnings on February 25, 2025 | Press release | -1.50% | +3.15% | |
| Form 10-Q AXON ENTERPRISE, INC. For: Sep 30 | SEC filing · Form 10-Q | +0.27% | +11.70% | |
| Axon reports Q3 2024 revenue of $544 million, up 32% year over year, raises outlook | Press release | +0.27% | +11.70% | |
| Axon to Release Third Quarter 2024 Earnings on November 7, 2024 | Press release | -0.33% | -0.36% | |
| Form 10-Q AXON ENTERPRISE, INC. For: Jun 30 | SEC filing · Form 10-Q | +1.90% | +5.83% | |
| Axon reports Q2 2024 revenue of $504 million, up 35% year over year, raises outlook | Press release | +1.90% | +5.83% | |
| Axon to Release Second Quarter 2024 Earnings on August 6, 2024 | Press release | -0.53% | -1.54% | |
| Form 10-Q AXON ENTERPRISE, INC. For: Mar 31 | SEC filing · Form 10-Q | -1.11% | -0.03% | |
| Axon reports Q1 2024 revenue of $461 million, up 34% year over year, raises outlook | Press release | -1.11% | -0.03% | |
| Axon to Release First Quarter 2024 Earnings on May 6, 2024 | Press release | +0.08% | +1.64% | |
| Form 10-K AXON ENTERPRISE, INC. For: Dec 31 | SEC filing · Form 10-K | -0.83% | +10.16% | |
| Axon to Release Fourth Quarter 2023 Earnings on February 27, 2024 | Press release | -0.53% | +1.05% | |
| Axon reports Q3 2023 revenue up 33% to $414 million, raises outlook | Press release | +2.90% | +2.26% | |
| Form 10-Q AXON ENTERPRISE, INC. For: Sep 30 | SEC filing · Form 10-Q | +2.90% | +2.26% | |
| Axon to Release Third Quarter 2023 Earnings on November 7, 2023 | Press release | -0.27% | -2.22% |
Keep exploring
More AXON: analyst actions → · SEC filings → · AXON overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| NEOS THERAPEUTICS (NEOS) | 479 | 0.00% | 48% |
| AKERS BIOSCIENCES INC COMMON S (AKER) | 478 | -0.87% | 33% |
| RXI PHARMACEUTICALS CORP (RXII) | 477 | -1.14% | 32% |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 477 | -0.11% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.